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A Second Amplifier Function
for the Allergy-Associated FceRI-b Subunit
chain binds the Fc portion of IgE with high affinity (Ha-
kimi et al., 1990; Blank et al., 1991; Robertson, 1993;
Sutton and Gould, 1993; Letourneur et al., 1995a). The b
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chain has four transmembrane domains between amino-Beth Israel Deaconess Medical Center and
and carboxyl-terminal cytoplasmic tails (Kinet et al.,Harvard Medical School
1988; Ra et al., 1989; Kuster et al., 1992). A homodimerBoston, Massachusetts 02215
of disulfide-linked g chains completes the tetrameric
structure (Blank et al., 1989; Ra et al., 1989; Kuster et
al., 1990). In humans, the tetrameric structure is not
Summary obligatory; an alternate form is present, comprising an
ag2 trimer (Miller et al., 1989; Kuster et al., 1990).Genetics studies have identified the gene for the high- In terms of devolution of function, the a chain con-
affinity IgE receptor (FceRI) b subunit as a candidate tains, in its extracellular part, two Ig-like domains that
gene for atopy. We have shown that b is an intrinsic mediate binding to IgE Fc (Hakimi et al., 1990; Blank et
signaling amplifier leading to enhanced allergic re- al., 1991; Mallamaci et al., 1993; Nissim et al., 1993;
sponses in vivo. Here we report that b has a second Robertson, 1993; Sutton and Gould, 1993; Presta et al.,
amplification function: the amplification of FceRI cell 1994; Cook et al., 1997; Garman et al., 1999; Hulett et
surface expression. This function is due to an early al., 1999), but its short cytoplasmic tail does not mediate
association of b with a, resulting in improved traffick- signal transduction (Alber et al., 1991). The b and g
ing and maturation of a and receptor complexes. chains contain conserved immunoreceptor tyrosine-
These data provide a possible molecular explanation based activation motifs (ITAM) in their cytoplasmic tails
for the large difference in FceRI density between b2 that are phosphoacceptors and through which b and g
cells such as monocytes, dendritic cells, and b1 ef- interact with signaling proteins (Reth, 1989; Letourneur
fector cells (mast cells, basophils). In b1 cells, the com- and Klausner, 1991; Romeo and Seed, 1991; Cambier,
bined signaling and expression amplification results 1995). However, b is unique in its function. In contrast
in an estimated 12- to 30-fold amplification of down- to other ITAM-containing chains, b does not appear to
stream events. possess any signaling capacity of its own but acts as
an amplifier of signals generated by the other ITAM-
containing chains of FceRI, the g chains (Jouvin et al.,Introduction
1994; Lin et al., 1996). At the same receptor density,
cells expressing the tetrameric FceRI abg2 generate sig-The FceRI complex forms a high-affinity cell surface
nals that are 3- to 5-fold stronger than those from cellsreceptor for the Fc region of immunoglobulin E (IgE)
lacking b (Lin et al., 1996). Similarly, systemic anaphylac-molecules (Kinet, 1999; Turner and Kinet, 1999). FceRI
tic responses are amplified in mice expressing the bis a member of a family of related antigen/Fc receptors
chain compared to mice expressing similar surfacethat have conserved structural features and play similar
FceRI levels but lacking the b chain (Dombrowicz et al.,roles in initiating intracellular signaling cascades. FceRI
1998).controls the activation of mast cells and basophils
The two human isoforms of FceRI, the tetramer abg2(Daeron, 1997; Kinet, 1999; Turner and Kinet, 1999) and
and the trimer ag2, have different cell distributions. Mastparticipates in IgE-mediated antigen presentation in
cells and basophils transcribe b and express the tetra-
monocytes and dendritic cells (Maurer et al., 1994, 1995,
mer, whereas monocytes, cutaneous Langerhans cells,
1998, 1996). Multivalent antigens bind and cross-link
and dermal and peripheral blood dendritic cells lack b
IgE molecules held at the cell surface by FceRI. Receptor transcripts and express only the trimer (Bieber et al.,
aggregation induces multiple signaling pathways that 1992; Wang et al., 1992; Maurer et al., 1994; Osterhoff
control diverse effector responses, including secretion et al., 1994). It seems that eosinophils may express tran-
of allergic mediators and induction of cytokine gene scripts for b, but it is unclear whether the protein is
transcription (including genes for IL-4, IL-6, TNFa, and translated (Gounni et al., 1994; Smith et al., 2000). An-
GM-CSF) (Galli and Costa, 1995). FceRI is therefore cen- other feature that separates these two groups of cell
tral to the induction and maintenance of an allergic re- types is the fact that FceRI surface expression is 10- to
sponse and, physiologically, may confer protection in 100-fold lower on cells that express the trimer (mono-
parasitic infections (Jankovic et al., 1997; Kinet, 1999). cytes, dendritic cells, and eosinophils) than on cells that
It is a conserved feature of antigen receptors that they express the tetrameric receptor (mast cells and baso-
are multimeric and devolve different functions to their phils) (Gounni et al., 1994; Sihra et al., 1997; Kita et al.,
individual subunits. In the case of FceRI, the receptor 1999). The reason for this difference in receptor density
is composed of three distinct protein species. The a is unknown. However, it is important to understand how
the difference is generated, since the receptors in the
FceRI b2 context are primarily thought to mediate anti-* To whom correspondence should be addressed (e-mail: jkinet@
gen presentation to T cells, while the FceRI b1 receptorscaregroup.harvard.edu).
mediate mast cell activation and subsequent release of² Present address: CNRS UMR 7627, Hospital PitieÂ SalpeÂ trieÁ re,
75013 Paris, France. allergic mediators. It is conceivable that the b chain, in
Immunity
516
Figure 1. Distribution of FceRI Expression in
U937 and NIH 3T3 Stable Transfectants
U937 (A) and NIH 3T3 (B) cell lines were stably
transfected with the a and g cDNAs or the a,
b, and g cDNAs. FceRI expression was ana-
lyzed on all the G418-resistant clones by flow
cytometry with biotinylated human IgE fol-
lowed by PE-conjugated streptavidin. Re-
sults are expressed as the mean fluorescence
intensity (MFI) for each clone. The mean for
each group is indicated by a white dot. This
is one experiment representative of three
(U937) and two (NIH 3T3) independent trans-
fections. The mean 6 SD for each group was
calculated. In each cell type the means for
ag2 and abg2 transfectants were compared
with an unpaired t test.
addition to its role as a signal amplifier, could also play shows the distribution of surface FceRI levels in clones
expressing ag2 and abg2. The ag2 transfectants expressa role in setting these different FceRI surface levels. This
raises the possibility that b may play more than one role 51.3 6 34.3 mean fluorescence intensity (MFI) units
(mean 6 SD) (n 5 23 clones), whereas abg2 transfectantsin defining the threshold and hence outcome of FceRI-
mediated responses. However, the question of a role express 217.4 6 136.2 MFI (n 5 31). This difference in
FceRI surface levels is highly significant (p 5 6 E-7). Afor b in regulating FceRI expression has not been investi-
gated. total of three transfections were performed indepen-
dently and yielded similar results (data not shown).The current study addresses the question of a possi-
ble role for b in receptor surface expression. We have We then investigated whether this effect was specific
to hematopoietic cells or could also be observed in agenerated multiple abg2 and ag2 transfectants for our
study of signaling amplification by b. Previously, we nonhematopoietic cell line, the fibroblast cell line NIH
3T3. Figure 1B shows that b also upregulates receptorhad selected abg2 and ag2 transfectants expressing the
same FceRI density in order to assess the intrinsic sig- expression in NIH 3T3. In this cell type, ag2 transfectants
express 30.2 6 24.2 MFI units (n 5 37), whereas abg2naling capacity of both forms of receptor. Here, we use
this system to examine the role of b in setting receptor transfectants express 208.7 6 207.8 MFI (n 5 13) (p 5
1 E-4). Another transfection performed independentlysurface levels. We show that the b chain facilitates FceRI
surface expression by promoting the processing and yielded similar results (data not shown).
export of the a chain to the cell surface and by enhancing These data establish a strong correlation between the
stability of receptor protein complexes. This represents presence of the b chain and the increased expression
a second amplifier function for b, where the presence or of the IgE binding a chain at the cell surface (4- to 6-fold
absence of b profoundly changes FceRI surface levels. increase) and show that no additional hematopoietic
specific factor seems to be necessary for this enhanced
Results expression.
abg2 FceRI Receptors Are More Highly Expressed
Increased Cell Surface Expression of IgE Bindingat the Cell Surface Than ag2
a Chain Is Due to the b ChainHuman FceRI is expressed as two isoforms, abg2 and
The easiest interpretation of the above results is that bag2, which have different cell type distributions. Baso-
itself facilitates the surface expression of a chain. In thisphils and mast cells, which transcribe the b chain, ex-
case, one would predict that ag2 -expressing cells thatpress 10±100 more receptors at the cell surface than
otherwise express stable levels of cell surface receptorsmonocytes, eosinophils, and dendritic cells, which do
should upregulate their receptor expression levels uponnot express b (Gounni et al., 1994; Sihra et al., 1997;
simple introduction of b. In order to test this hypothesis,Kita et al., 1999). In an effort to understand the receptor
we first generated ag2 stable transfectants in KU812, adensity difference between abg2- and ag2-expressing
basophilic cell line with no endogenous expression ofcells, we have tested the hypothesis that the b chain
FceRI at the cell surface. We then transfected transientlycould be responsible for increased FceRI at the cell
one of these stable ag2 clones with the b cDNA or withsurface.
an irrelevant DNA and with a construct encoding theWe have generated stable transfectants expressing
green fluorescent protein (GFP) to control for transfec-either form of FceRI and analyzed their spectrum of
tion efficiency. Surface levels of FceRI were measuredreceptor expression. U937 cells were stably transfected
8±48 hr after retransfection (Figure 2). Indeed, receptorwith either the a, b, and g cDNAs or the a and g cDNAs,
expression is higher after b transfection compared toand all the selection-resistant clones were expanded
control transfection at all time points. At 48 hr, b inducesand analyzed in order to assess the whole range of
a FceRI expression level of 164 MFI units compared toreceptor expression. Surface FceRI expression was ana-
lyzed by flow cytometry after staining with IgE. Figure 1A 92 for the control cDNA (p 5 3.3 E-5). Thus, the b chain
A Second Amplifier Function of the FceRI-b Subunit
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Figure 2. FceRI Levels in ag2 Cells after Retransfection with b
KU812 clone stably expressing ag2 was transiently cotransfected
with the b cDNA (closed circles) or a control cDNA (open squares)
and with a GFP construct. Cells were stained as in Figure 1. Results
from two to three experiments for each time point are expressed
as MFI of GFP-positive cells at different times after transfection.
The means 6 SD for each group were calculated and compared
between b and control retransfections at each time point (asterisk,
NS; number sign, p 5 2.1E-3; plus, p 5 3.3 E-5).
is specifically responsible for increasing a chain expres-
sion. Note, however, that the lower intensity of the ex-
pression amplifying effect when b is expressed tran-
siently (less than 2-fold increase) compared to that when
b is stably expressed (4- to 6-fold increase) is likely due
to the presence of non-b expressing cells in the GFP-
positive population and of dividing cells, which do not
replicate the nonintegrated transfected b construct. In
spite of this caveat, this experiment establishes qualita-
tively that the b chain is specifically responsible for in-
Figure 3. Immature a Is More Stable in ag2 Clones Than in abg2
creasing the surface expression of IgE binding a chain. Clones
One ag2 and one abg2 clone with comparable surface FceRI expres-
The b Chain Amplification of a Chain Surface sion levels were pulsed for 15 min and then analyzed immediately
(chase 0 min) or after 45 or 90 min chase. Cells lysates were immuno-Expression Is Posttranslational
precipitated with the anti-a mAb 15-1 and separated by SDS-PAGE.We then investigated whether the b chain could increase
(A) FceRI expression of the abg2 clone and the ag2 clone used in (B)the expression of IgE binding a chain at the level of
was measured by flow cytometry after staining with the anti-a mAb
synthesis and/or processing of the a chain in a pulse- 15-1 followed by FITC-GAM. Left panel, ag clone; right panel, abg
chase experiment. We compared the rate of accumula- clone. Untransfected cells (thin line) were analyzed in parallel.
tion of nascent a chain in abg2 and in ag2 clones using (B) SDS-PAGE analysis showing the immature a bands after 0, 45,
and 90 min chase.an abg2 clone with a higher level of cell surface a chain
(C) Plot of the immature a band intensity in arbitrary units as athan the ag2 clone (Figure 3A). The cells were pulsed for
function of time for the ag2 and abg2 clones shown in (B).15 min with a [35S]methionine/cysteine labeling cocktail
and chased for 0, 45, or 90 min with a cold amino acid
mixture. The lysates were then immunoprecipitated with
clone even though the abg2 clone expresses more sur-an anti-a monoclonal antibody, 15-1, and the immuno-
face a chain than the ag2 clone. In that experiment, thecomplexes were resolved by SDS-PAGE (Figure 3B).
accumulated nascent a chain seen after 30 min is almostThe intensity of the bands corresponding to nascent a
cut by half after 60 min chase in the abg2 clone, but itchain was quantified and plotted as a function of time
continues to increase in the ag2 clone. Together, these(Figure 3C). If the increased cell surface expression of
data indicate that the presence of the b chain does not
a chain seen in abg2 cells is due to a positive effect of result in an increased a chain synthesis but induces anthe b chain on a chain synthesis, one should expect the
acceleration of the a chain processing. Thus, in ag2-rate of accumulation of nascent a chain to be higher in
expressing cells, there is a relative retention of the newly
abg2 cells than in ag2 cells. However, these data show synthesized a chain while there is a relative disappear-that at time 0, there is more nascent a chain accumu-
ance of the nascent a chain in abg2-expressing cells.lated in the ag2 than in the abg2 clone. Moreover, the
accumulation of nascent a chain in the ag2 clone in-
creases substantially at 45 min and remains stable after FceRIa and b Associate Early
in the Endoplasmic Reticulum90 min of chase. In contrast, the accumulation seen in
the abg2 clone after 45 min is lower than in the ag2 clone It is clear from the analyses presented above that the
presence of FceRIb accelerates the processing of na-and decreases substantially after 90 min. Another such
experiment (data not shown) confirmed that there is less scent a chains and enhances the cell surface expression
of a, suggesting that b may affect (1) the tendency of anascent a chain accumulated in an abg2 than in an ag2
Immunity
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Figure 5. FceRI abg2 Are More Stable in the Presence of Detergents
Than ag2 Complexes
The same abg2 and ag2 clones as in Figure 4 were lysed in a buffer
containing either 0.5% Triton X-100 (Tx) or 1% digitonin (Dg). Lysates
were precipitated with anti-a mAb, subjected to SDS-PAGE, and
immunoblotted with anti-b (upper panel) and anti-g (lower panel)
Abs.
attainment by new FceRI protein complexes. We tested
the idea that b chains may enhance the stability of recep-
tor complexes, an effect that would have implications
for FceRI complexes both during synthesis and when
finally assembled at the cell surface.
Figure 4. FceRI a and b Associate Very Early after Biosynthesis in In the cell, entropy determines that nascent and as-
the ER
sembled protein complexes will exist in a state of equi-
(A) Surface FceRI expression of the abg2 clone and the ag2 clone librium where the tendency to dissociate is balanced by
used in (B) was measured by flow cytometry after staining with the
intermolecular forces of attraction and stabilization. Weanti-a mAb 1511 followed by FITC-GAM. Left panel, U937 clone
attempted to mimic the action of the forces that tendtransfected with a and g cDNAs; right panel, U937 clone transfected
with a, b, and g cDNAs. Untransfected cells (thin line) were analyzed to dissociate protein complexes in vivo using the in vitro
in parallel. application of detergents of various stringencies. We
(B) The ag2 and abg2 U937 transfectants shown in (A) were pulsed compared the stability of abg2 and ag2 FceRI complexes
with a metabolic labeling cocktail (70% [35S]methionine, 15% in vitro in the presence of digitonin and Triton X-100,
[35S]cysteine) for 5 min followed by a chase for the indicated times.
the latter being a harsher dissociating agent than theLysates were immunoprecipitated with the anti-a mAb 15-1 and
former. The data in Figure 5 show the results of thisresolved by SDS-PAGE.
comparison. Postnuclear lysates were prepared from
either ag2- or abg2-expressing clonal cell lines, usingchains to progress through the endoplasmic reticulum
either Triton X-100 or digitonin as the disrupting deter-(ER)/Golgi and attain the cell surface and/or (2) the sta-
gent. Immunocomplexes were purified using an anti-ability of assembled FceRI during synthesis or at the cell
monoclonal antibody and the presence of copurified bsurface. We hypothesize that for either case to be an
or g chains was assessed by specific Western analysis.important mechanism, a and b association must occur
It is clear that the presence of b allows copurificationearly in the process of biosynthesis. The issue of when
of bg complexes in both detergent conditions, while inthe a/b association is first established has not previously
the absence of b the association between a and g isbeen addressed.
completely disrupted by Triton X-100. Thus, where anWe performed a pulse-chase experiment to analyze
exogenous dissociating agent is applied, the presencethe dynamics of the ab association. One ag2 and one
of b helps maintain the FceRI complex. We would inter-abg2 clone with similar levels of surface expression (Fig-
pret this to mean that, in vivo, the b-containing FceRIure 4A) were pulsed for 5 min with a [35S]methionine/
would be more stable than ag receptors, both duringcysteine labeling cocktail and chased for 0, 7, or 15 min
biosynthesis and once expressed at the cell surface.with a cold amino acid mixture. The lysates were then
immunoprecipitated with an anti-a monoclonal anti-
FceRIb Enhances the Trafficking and Maturationbody, 15-1, and immunocomplexes were resolved by
of a ChainsSDS-PAGE (Figure 4B). In the abg2 clone, b can be co-
We have shown that FceRIb associates very early in theprecipitated with a after 5 min labeling and 0 min chase.
ER with a chains, enhances the stability of receptorThus, a and b can be coimmunoprecipitated after no
complexes, accelerates the processing of nascent amore than 5 min of protein synthesis has taken place.
chain, and enhances the surface expression of receptorThese results indicate that the a/b interaction occurs
complexes. If indeed the acceleration of processing ofvery early in biosynthesis while both nascent receptor
a in the ER due to b and the outcome at the cell surfacechains are still in the ER.
are connected, then an effect of b on maturation and
trafficking of a chains should be present. In that case,Increased Stability in Detergent of abg2 Complexes
one should expect that abg2 cells and ag2 cells withCompared to ag2 Receptors
similar levels of FceRI on the cell surface have veryWe next wished to ask what advantage was conferred
by the presence of b that resulted in improved surface different steady state levels of immature a chain, and
A Second Amplifier Function of the FceRI-b Subunit
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Figure 6. ag2 Clones Contain More Immature a Than abg2 Clones
for the Same Level of Surface FceRI
The same clones as in Figure 4 were analyzed. Cells were lysed and
immunoprecipitated with the anti-a mAb 15-1. Immune complexes
were treated (plus) or not (minus) with endoglycosidase H (endo H),
subjected to SDS-PAGE and transferred to PVDF membrane. Mature
and immature forms of a were revealed by immunoblotting with
anti-a polyclonal Ab 997.
these steady state levels should be lower in abg2 cells
than in ag2 cells.
We have exploited a chain glycosylation to follow pro-
cessing of the receptor complex in the presence and
the absence of the b chain. The a chain is highly and
heterogeneously N-glycosylated, with about 50% of the
molecular weight of cell surface a due to sugars. The
newly synthesized a chain is core-glycosylated (man-
nose rich) in the ER and is thus sensitive to the action
of endoglycosidase H (endo H). It then is transferred to
the Golgi, where terminal glycosylation occurs, which Figure 7. The Presence of the b Chain Favors the a Chain Matu-
rationreplaces mannose rich sugars with complex sugars that
are endo H resistant. Thus, these various forms of a can (A) Three abg2 and three ag2 clones with low, medium, and high
FceRI expression levels were analyzed by Western blotting afterbe distinguished by a combination of endo H treatment
immunoprecipitation with an anti-a Ab. The intensities of the bandsand SDS-PAGE.
corresponding to mature and immature a (as defined in Figure 6)ag2 and abg2 clones with similar levels of FceRI surface were measured by scanning densitometry. For each clone the inten-
expression (same clones as in Figure 4A) were lysed sity of the mature a bands was plotted as a function of the intensity
and the a chains precipitated with anti-a mAb (15-1), of the immature a bands.
which can precipitate both mature and immature forms (B) The ratio between mature a and immature a in three (abg2) and
two (ag2) uncloned stably transfected populations and three ag2 andof a (Letourneur et al., 1995a). The samples were then
three abg2 clones was calculated from experiments similar to thetreated, or not, with endo H and resolved by SDS-PAGE.
one depicted in (A). Results are expressed as mean 6 SD. TheWestern analysis was performed using a polyclonal
means 6 SD for each group were calculated and compared using
anti-a antibody (997) (Figure 6). Two forms of a are an unpaired t test.
present in both abg2 and ag2 clones. A form around 46
kDa gives rise, after endo H treatment, to a band at
statistical calculations, we then analyzed more samples
around 30 kDa, which is the expected molecular weight (five of each type) and calculated the ratio between
for the core protein. This form represents the immature mature a and immature a (Figure 7B). The mature a/imma-
ER a. A smear around 66 kDa is mainly endo H insensi- ture a ratio is significantly higher in the abg2 cells (4.33 6
tive and represents mature a. These data show that in 2.38, mean 6 SD) than in the ag2 cells (1.03 6 0.6) (p 5
two clones expressing similar levels of surface FceRI, 0.039). Taken together with the pulse-chase experimen-
the amount of immature a chain is much greater at tal results that demonstrate an accelerated processing
steady state in the ag2 clone than in the abg2 clone. of a chain in the presence of the b chain, these data
To investigate whether the same observation could demonstrate that a maturation is considerably improved
be made in clones with very different levels of surface in the presence of the b chain. Remarkably, the in-
expressed FceRI, we performed a similar analysis with creased ratio (4-fold increase) that reflects the improve-
three abg2 and three ag2 clones, one each with low, ment of the processing of a correlates closely with the
medium, or high FceRI expression levels. For each clone increased surface expression described in Figure 1 (4-
the intensity of the mature a band was plotted as a to 6-fold increase), suggesting that the majority of the
function of the intensity of the immature a band (Figure surface expression increase is due to improved pro-
7A). This plot shows that ag2 clones require much more cessing. Thus, a maturation is considerably improved
immature a chain in the ER to express the same level in the presence of the b chain, linking the early associa-
tion of a and b and the enhanced stability of b-containingof mature a chain than abg2 clones. In order to perform
Immunity
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complexes to the phenotype of b amplification of recep- for rodent FceRI expression is also responsible for the
expression amplifier effect in the human system. Thetor surface expression.
inability of rodent a to be expressed at the cell surface
with g in the absence of b points toward a feature spe-Discussion
cific to rodent a. Thus, a is either incapable (rodent), or
poorly capable (human) of trafficking to the cell surfaceHuman FceRI is expressed as two isoforms, abg2 and
with the g chain alone. This dependence on b for aag2. These two isoforms differ in their capacity to signal,
expression at the cell surface could be due to the pres-the tetramer abg2 being 3- to 5-fold more active than
ence of an ER retention motif in the a chain that wouldthe trimer ag2. This difference is due to the b chain,
be masked by the b chain, by analogy with a similarwhich acts as an amplifier of signals generated by the
motif in the intracellular tail of a that is masked by the gg chain, causing an enhancement in Syk tyrosine phos-
chain (Letourneur et al., 1995b). The additional retentionphorylation, Syk kinase activity, and intracellular cal-
motif that we propose here would be located in thecium mobilization (Lin et al., 1996). These effects trans-
extracellular part of rodent a, since the extracellular partlate directly in vivo to enhanced systemic anaphylactic
of human but not rodent a can be expressed by itselfresponses (Dombrowicz et al., 1998). Here we show that
as a soluble protein (Blank et al., 1991).in addition to this enhancement of signaling by mature
The recently elucidated crystal structure of the extra-surface-expressed receptors, b is an amplifier of recep-
cellular part of the FceRI a may provide insight into itstor expression.
site of interaction with b. The two Ig domains of a areWe have used a reconstitution system to demonstrate
positioned at an acute angle to one another, forming athe expression amplifying role of b. In this system
convex surface at the top of the molecule, where sometransfectants were generated with either the a, b, and
of the amino acids previously implicated in IgE bindingg cDNAs or only the a and g cDNAs. In the hematopoietic
are located, and a marked cleft enclosed by the twocell line U937, abg2 transfectants express on average
globular Ig domains that faces the plasma membrane4-fold more receptors than ag2 transfectants. b also acts
and is not involved in IgE binding. This configurationas a receptor amplifier in a heterologous cell line, the
suggests that residues located in this cleft could beNIH 3T3 fibroblast cell line, where abg2 transfectants
involved in the interaction with b and g.express on average almost 6-fold more receptors than
The FceRI expression amplifier role of b may explainag2 transfectants (Figure 1). That b is directly responsible the fact that mast cells and basophils, which transcribefor this expression amplification is demonstrated by its
b, express 10±100 more surface FceRI than monocytesability to upregulate FceRI surface expression when
and dendritic cells, which lack b. Eosinophils expresstransfected transiently in stable ag2-expressing cells very low surface levels of FceRI, however, the a and g(Figure 2). We also present biochemical data on the
proteins, but not b, can be detected inside the cellsmechanism by which this amplification function of b
(Seminario et al., 1999). This suggests that in the ab-is mediated. We show that b acts by accelerating the
sence of b, most ag2 complexes do not proceed to theprocessing of nascent a chain (Figure 3) and by promot-
surface. This phenomenon parallels what we have ob-
ing the maturation of the IgE binding a chain (Figures 6
served with transfected cells, where a larger amount of
and 7). This effect is likely mediated by an early associa-
immature a compared to mature a is present inside
tion between a and b in the ER (Figure 4) and possibly
the cell in ag2 transfectants than in abg2 transfectantsby an increased stability of the nascent FceRI complex, (Figures 6 and 7). These two observations suggest a
as shown by the higher resistance to detergent dissocia- mechanism for the expression amplifier function of b by
tion of abg2 complexes when compared to ag2 com- which b would act as a sort of chaperone for a during
plexes (Figure 5). maturation. Such a mechanism has been demonstrated
The important receptor expression amplifying func- for other multimeric membrane proteins such as, for
tion of b has not been studied or described previously. example, the voltage-gated potassium channel Kv1.2.
When we investigated the signal amplifying function of One of the b subunits, Kvb2, increases efficiency of
b, it was critical that we compare transfected cell lines Kv1.2 surface expression by associating cotranslation-
(and engineered mouse strains) expressing comparable ally with the Kv1.2 a subunit, promoting N-glycosylation
levels of surface FceRI. Therefore, for functional analysis of Kv1.2 a and increasing stability of Kvb2/Kv1.2 com-
we selected abg2 and ag2 clones with matching FceRI plexes (Shi et al., 1996). FceRI shares some characteris-
expression. This strategy allowed us to demonstrate tics with this system. First, glycosylation of the a chain
that the signal amplifier function is an intrinsic property is required for efficient processing in eukaryotic cells,
of b and not a consequence of higher FceRI expression. which indicates that it is necessary for interaction with
However, it masked the receptor expression±amplifying the eukaryotic cell machinery but is not required for
function of b, which became apparent only when we expression of the protein per se (Letourneur et al.,
analyzed all the abg2 and ag2 selection-resistant clones. 1995a). Second, a and b associate very early after de
In human FceRI, in contrast to rodent FceRI, b is dis- novo protein synthesis (Figure 4). Third, FceRI ag2 com-
pensable for receptor expression. However, the human plexes dissociate more easily than abg2 complexes in
receptor expression±amplifying function of human b detergent (Figure 5). Fourth, a glycosylation maturation
suggests that the difference between the human and is more efficient in the presence of b (Figures 6 and 7).
rodent systems may be more of degree than nature, We have measured the increase in FceRI attainment
with a requirement for b in the rodent system and an of the cell surface in the presence and absence of the
actively positive effect of b in the human system. There- b chain. Overall, b appears to increase receptor expres-
sion at the cell surface 4- to 6-fold. When combinedfore, it appears likely that what makes b mandatory
A Second Amplifier Function of the FceRI-b Subunit
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b 961, the monoclonal (mAb) (15-1) and polyclonal (997) anti-humanwith the 3- to 5-fold signal amplification that we have
FceRI a, and the polyclonal anti-g chain antibodies (Ab) were pre-calculated b to confer upon FceRI responses to antigen,
pared as described (Letourneur et al., 1991, 1995; Wang et al., 1992;the overall effect of having b in an FceRI complex is
Maurer et al., 1996). Human IgE was from Dr. Z. Eshhar (Schwarzbaum
likely to be a 12- to 30-fold amplification of downstream et al., 1989).
events. FceRI b is thus an extremely important modula-
tor of outcomes in the generation and maintenance of Construction of Stable Transfectants
The human a and g cDNAs were subcloned in the pCDL SRa296an allergic response.
eukaryotic expression vector (Yokota et al., 1986), the human bThis property of b raises the important question of
cDNA in the pBJ1neo eukaryotic expression vector containing awhy a mechanism for generating such a substantial am-
neo resistance cassette (Lin et al., 1990). When the a and g but not bplification of antigen-derived signals has evolved. One
cDNAs were cotransfected, the empty pBJ1neo was cotransfected.
possibility would be to compensate for the relatively U937 and NIH 3T3 cells were cotransfected as described (Lin et al.,
low levels of serum IgE present even in patients with 1996). Stable transfectants in the KU812 cells were generated by
parasitic infections, a situation in which the protective electroporation (300 volts, 960 mF) with the a and g constructs and
selected with G418.benefit of an IgE response has been suggested (Hagan
et al., 1991). The flip side of this effect is the fact that
Transient Transfectionmast cell responses to tiny amounts of antigen/IgE may
KU812 stable transfectants expressing FceRI ag2 (5 3 106 cells) werebe amplified to potentially devastating levels of effector
cotransfected by electroporation with 10 mg pBJ1neo b construct
response, resulting in allergic and anaphylactic pa- and 1 mg green fluorescent protein construct (pGreen Lantern, Life
thology. Science, Bethesda, MD).
In humans, FceRI-expressing cells are divided into
Assessment of FceRI Expression by Surface Stainingtwo groups, b1 and b2. Our data make it clear that
and Flow Cytometrythis difference will translate to vastly different cellular
Cells were stained with 1 mg biotinylated IgE, followed by streptavi-responses to antigen/IgE. Human cells expressing b-con-
din-phycoerythrin (SA-PE) (1:200) (PharMingen, San Diego, CA) andtaining FceRI are those involved in allergic mediator se-
analyzed on a FACSCalibur flow cytometer (Becton Dickinson,
cretion, whereas cells lacking b are primarily thought to Franklin Lakes, NJ). Alternatively, cells were stained with anti-a mAb
use FceRI for antigen presentation, since antigen pre- 15-1 followed by FITC-conjugated goat-anti mouse. Untransfected
sentation by monocytes is much more efficient when cells were processed in parallel and used as negative control.
antigen contacts these cells via binding of antigen-spe-
Immunoprecipitation and Western Blottingcific IgE to FceRI than in the absence of specific IgE
Cell lysis and immunoprecipitation were performed as previously(Maurer et al., 1995, 1998). By analogy, eosinophils could
described (Lin et al., 1996). Briefly, cells were lysed at a ratio of 3 3also be involved in antigen presentation (Gounni et al.,
107 cells/ml of lysis buffer (0.5% Triton X-100, 150 mM NaCl, 200 mM
1994; Kita et al., 1999). Lack of the b chain on monocytes boric acid [pH 8.0]), supplemented with the ªCompleteº protease
and dendritic cells, and possibly eosinophils, may reflect inhibitor cocktail (Roche Molecular Biochemicals, Indianapolis, IN).
the following: first, that lower FceRI surface levels are In some experiments, cells were lysed in 1% digitonin instead of
0.5% Triton X-100. Where indicated, immunoprecipitates weremore appropriate for antigen presentation than for
treated with endo-b-N-acetylglucosamidase (endo H) (New EnglandFceRI-mediated effector cell activation, thus, there is
Biolabs, Beverly, MA) as previously described (Letourneur et al.,no need for the b chain to promote the energetically
1995a). Samples were resolved on SDS 13% polyacrylamide gel,
expensive trafficking of high levels of FceRI to the sur- transferred to PVDF membrane, and blotted with the antibodies
face. Second, additional signal amplification, as pro- indicated. Immunoreactive proteins were visualized using alkaline
vided by the b chain, may be unnecessary on cells where phosphatase±coupled second-step reagents and enhanced chemi-
fluorescence (ECF, Amersham). Fluorescence was quantified usingno or little effector response is to be induced by antigen.
a Storm scanner (Molecular Dynamics, Sunnyvale, CA).The lack of b chain may even serve to actively avoid
any induction of inappropriate signaling pathways using
Pulse-Chase Analysismonocyte or dendritic cell signaling proteins that are
Cells were incubated in cysteine- and methionine-free RPMI medium
present in order to transduce signals from other recep- containing 10% dialyzed FBS (Biofluids, Rockville, MD) for 20 min
tors such as the FcgR family. Some minimal signaling at 378C. The cells at 5 3 106/ml were then pulsed with 0.2 mCi/
is observed after ligation of monocyte ag2 receptor ml TRAN 35S-LABEL (70% [35S]methionine, 15% [35S]cysteine) (ICN
Biomedicals, Costa Mesa, CA) for 5±15 min at 378C. An aliquot of(Maurer et al., 1994), and the biological significance and
15 3 106 cells was collected at time 0, and the remaining cells wereoutcomes of these signals in the context of an IgE-driven
washed and resuspended in complete medium supplemented withimmune response remain to be investigated.
cysteine and methionine for various periods of chase. At each timeSince b has been proposed as a candidate gene for
point, 15 3 106 cells were pelleted by centrifugation, washed twice
atopy, the new expression-amplifying function de- with ice-cold PBS, and resuspended in 0.5 ml of ice-cold lysis buffer
scribed here, in addition to the known signaling-ampli- (0.5% Triton X-100, 300 mM NaCl, 50 mM Tris [pH 7.5] in the pres-
fier function of b, reinforces the importance of b as a key ence of protease inhibitors).
modulator in allergy, and any process able to increase b
Statisticsexpression will translate into drastic enhancement of
Averages are expressed 6 SD. Comparisons between groups wereFceRI-mediated response.
performed with the Student's unpaired t test.
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